Home›People›Nicholas Walrod
NW

Nicholas Walrod

Director at Claros Technologies. Also a director at Bonum Therapeutics, Source Global and Fervo Energy.

DirectorRoles at 4 startups
Updated Nov 10, 2026·Latest SEC filing Jul 22, 2026·Suggest an edit

About Nicholas Walrod

Nicholas Walrod is a director at Claros Technologies.

Form D filings also name Nicholas Walrod as a director at Bonum Therapeutics, Source Global and Fervo Energy.

Nicholas Walrod first appears on SEC filings in 2015.

Experience

This experience comes from Nicholas Walrod's profile and from SEC filings. For roles taken from filings, the years are when the filings name Nicholas Walrod in the role, so the role may have started earlier or lasted longer.

American Century Investments Current
Managing Partner, Private Investments Team
2023 – Present
Claros Technologies, Inc. Current
Board of Directors
2021 – Present · Minneapolis, MN
PFAS testing and destruction systems for industrial manufacturers and other organizations.
503 Partners (formerly 3x5 Partners) Current
Managing Partner, Co-Founder
2011 – Present
Yarg Foundation Current
Board Member
2011 – Present
Dancing Moon Farm Current
Farmer
2004 – Present
Bonum Therapeutics, Inc.
Board of Directors
2021 – 2026 · Seattle, WA
Develops targeted protein medicines for people with cancer.
Enzinc
Board Member
2025 – 2026
Fervo Energy Co
Board of Directors
2019 – 2026 · Houston, TX
Source Global, PBC
Board Of Directors
2015 – 2025 · Scottsdale, AZ
Smart Wires Inc.
Board Of Directors
2011 – 2025
Good Therapeutics, Inc.
Board of Directors
2019 – 2022
Rubicon Global
Board of Directors
2014 – 2022
Fishpeople, Inc.
Board of Directors
2012 – 2021
Northwest Area Foundation
Board of Directors
2013 – 2019
Vapotherm
Board Observer
2014 – 2018
Securus Medical Group, Inc
Board of Directors
2013 – 2018
Gray Family Foundation (Portland, OR)
Board Member
2011 – 2017
Pacific Northwest College of Art
Board of Governors
2003 – 2013
AMERICAN LEADERSHIP FORUM OF OREGON
Senior Fellow
2011 – 2012
Gorge Grown Food Network
Board Member
2005 – 2011

Key Colleagues at Startups

The people Nicholas Walrod works with at each company, as listed on that company's latest Form D.

Claros Technologies, Inc. · Form D, Jul 22, 2026
Michelle Bellanca
Michelle Bellanca
CEO & Co-Founder, director
Kyle King
Kyle King
Chief Financial Officer
JL
James Leslie
Director
Bonum Therapeutics, Inc. · Form D, Apr 17, 2026
Samuel Bjork
Samuel Bjork
Executive Chair
Monique Schiersing
Monique Schiersing
Senior Investment Director, Roche Venture
Neela Patel
Neela Patel
Chief Business Officer
JM
John McKearn
Director
Diane Hollenbaugh
Diane Hollenbaugh
Chief Scientific Officer
Samuel Blackman
Samuel Blackman
Independent Director
John Mulligan
John Mulligan
Chief Executive Officer and director
Karl Handelsman
Karl Handelsman
Founder & Managing Partner, Codon Capital, director
MM
Mitchell Mutz
Independent Director
Gaurav Aggarwal
Gaurav Aggarwal
Managing Partner, Vivo Capital and director
Source Global, PBC · Form D, Apr 29, 2022
AM
AA
Amy Ard
Director
DC
David Crane
Director
CF
Cody Friesen
President and CEO, director
Fervo Energy Co · Form D, Apr 2, 2021
TL
Timothy Latimer
President and director
DD
JN
Jack Norbeck
Director
IY

Sources

  1. SECClaros Technologies, Inc. Form D, filed Jul 22, 2026
  2. SECBonum Therapeutics, Inc. Form D, filed Apr 17, 2026
  3. SECSource Global, PBC Form D, filed Apr 29, 2022
  4. SECFervo Energy Co Form D, filed Apr 2, 2021